Literature DB >> 3402630

Patterns of visual loss in untreated sickle cell retinopathy.

B J Moriarty1, R W Acheson, P I Condon, G R Serjeant.   

Abstract

Ophthalmic assessments of 120 patients with homozygous sickle cell (SS) disease and of 222 with sickle cell haemoglobin-C (SC) disease were conducted over a period of ten years. Visual acuity loss (V.A. less than or equal to 6/18) attributable to sickle cell retinopathy occurred in 10% of untreated eyes during a mean observation period of 6.9 years. Visual loss was strongly associated with proliferative sickle retinopathy (p less than 0.001) and most commonly resulted from vitreous haemorrhage, tractional retinal detachment and epiretinal membranes. The incidence of visual loss was 31 per 1000 eye-years observation among eyes with proliferative disease compared to 1.4 per 1000 eye-years observation among eyes with non-proliferative disease.

Entities:  

Mesh:

Year:  1988        PMID: 3402630     DOI: 10.1038/eye.1988.62

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

1.  Influence of genotype on the natural history of untreated proliferative sickle retinopathy--an angiographic study.

Authors:  P D Fox; S J Vessey; M L Forshaw; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

2.  The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.

Authors:  J S Mohan; P L Lip; A D Blann; D Bareford; G Y H Lip
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 3.  New Ways to Detect Pediatric Sickle Cell Retinopathy: A Comprehensive Review.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Royce W S Chen
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

4.  A comparison of 23-gauge and 20-gauge vitrectomy for proliferative sickle cell retinopathy - clinical outcomes and surgical management.

Authors:  Jason Ho; Anna Grabowska; Marta Ugarte; Mahiul Mk Muqit
Journal:  Eye (Lond)       Date:  2018-05-22       Impact factor: 3.775

5.  Structural and functional correlation in sickle cell retinopathy using spectral-domain optical coherence tomography and scanning laser ophthalmoscope microperimetry.

Authors:  Clement C Chow; Mohamed A Genead; Anastasios Anastasakis; Felix Y Chau; Gerald A Fishman; Jennifer I Lim
Journal:  Am J Ophthalmol       Date:  2011-07-02       Impact factor: 5.258

6.  Outcome of iatrogenic choroidal neovascularisation in sickle cell disease.

Authors:  P D Fox; R W Acheson; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

7.  Optical Coherence Tomography Angiography and Ultra-widefield Fluorescein Angiography for Early Detection of Adolescent Sickle Retinopathy.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Margaret T Lee; Jonathan S Chang; Maureen Licursi; Courtney Briamonte; Elana Smilow; Royce W S Chen
Journal:  Am J Ophthalmol       Date:  2017-08-30       Impact factor: 5.258

8.  The ocular manifestations of sickle-cell disease: a prevalence and natural history study.

Authors:  J G Clarkson
Journal:  Trans Am Ophthalmol Soc       Date:  1992

Review 9.  The past, present and future management of sickle cell retinopathy within an African context.

Authors:  Kwesi Nyan Amissah-Arthur; Evelyn Mensah
Journal:  Eye (Lond)       Date:  2018-07-10       Impact factor: 3.775

Review 10.  Laser therapy for retinopathy in sickle cell disease.

Authors:  Kay Thi Myint; Soumendra Sahoo; Aung Win Thein; Soe Moe; Han Ni
Journal:  Cochrane Database Syst Rev       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.